Discontinuation report JAMP-LOSARTAN HCTZ
| Report ID | 168990 |
| Drug Identification Number | 02408244 |
| Brand name | JAMP-LOSARTAN HCTZ |
| Common or Proper name | Losartan potassium and Hydrochlorothiazide tablets |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM |
| Strength(s) | 12.5MG 50MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 30 |
| ATC code | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2022-09-06 |
| Remaining supply date | 2022-01-31 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2022-09-09 | French | Compare |
| v1 | 2022-09-09 | English | Compare |
Showing 1 to 2 of 2